Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

RTTNews | 589天前
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins

(RTTNews) - Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.

This collaboration will leverage Ginkgo Protein Expression Services and Imagindairy's process development and scale-up expertise to accelerate the development of functional non-whey dairy proteins.

This is a multi-year program, funded in part by a joint grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

Imagindairy and Ginkgo have partnered to design an optimized organism capable of cost-effectively producing non-whey dairy proteins. This will allow Imagindairy to remain focused on whey protein production and commercialization while accelerating time to market of non-whey proteins.

read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets

Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews | 573天前
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges

Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews | 665天前
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Ginkgo Bioworks To Acquire Zymergen In All-stock Deal

Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews | 1199天前
Japanese Market Sharply Higher

Japanese Market Sharply Higher

The Japanese market is sharply higher on Thursday, snapping a five-session losing streak, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is moving up almost 2 percent to above the 50,900 level, with gains across most sectors led by index heavyweights, exporters and financial stocks.
RTTNews | 1小時2分鐘前
Thai Stock Market May Reclaim 1,300-Point Plateau

Thai Stock Market May Reclaim 1,300-Point Plateau

The Thai stock market has moved lower in five straight sessions, slumping more than 15 points or 1.2 percent along the way. The Stock Exchange of Thailand now sits just shy of the 1,300-point plateau although it's expected to open to the upside on Thursday.
RTTNews | 1小時34分鐘前